TWiV 1014: Clinical update with Dr. Daniel Griffin
Episode

TWiV 1014: Clinical update with Dr. Daniel Griffin

From This Week in Virology Vincent Racaniello
In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagulation therapy for COVID-19 hospitalized adults in the United States, development of a definition of postacute sequelae of SARS-CoV-2 infection, neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms, long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms, and coronary microvascular health in symptomatic patients with prior COVID-19 infection. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Estimates of SARS-CoV-2 seroprevalence and incidence of infections among blood donors, by vaccination status (CDC) Smart thermometer–based surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic (JAMA) COVID-19 vaccine mandates (GOV) Changing epidemiology of adults hospitalized with COVID-19 after introduction of vaccines (CID) Effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. Veterans (ACP Journals) National trends in Anticoagulation therapy for COVID-19 (IDSA) Development of a definition of postacute sequelae of SARS-CoV-2 infection (JAMA) Neuroinflammation after COVID-19 with depressive and cognitive symptoms (JAMA) Long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms (OFID) Coronary microvascular health in patients with prior COVID-19 infection (EACVI) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1014 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Community discussion